contains three open reading frames. Of these, ORF1 encodes the viral nonstructural polyprotein; ORF2 encodes the major capsid protein and ORF3 codes for a phosphoprotein of undefined function. Using the yeast two-hybrid system to screen a human cDNA liver library we have isolated, an N-terminal deleted protein, ␣ 1 -microglobulin/bikunin precursor (AMBP) that specifically interacts with the ORF3 protein of HEV. Independently cloned, full-length AMBP was obtained and tested positive for interaction with ORF3 using a variety of in vivo and in vitro techniques. AMBP, a liver-specific precursor protein codes for two different unrelated proteins 
Hepatitis E virus (HEV)
1 is a waterborne pathogen and is responsible for sporadic infections as well as large epidemics of acute viral hepatitis in developing countries (1) (2) (3) (4) . HEV is a plus-stranded RNA virus with a genome of ϳ7.2 kb, containing three open reading frames called ORF1, ORF2, and ORF3 (5-7). ORF1 (5079 bp) is at the 5Ј-end of the genome and is predicted to code for putative non-structural proteins with sequences homologous to those encoding a viral methyltransferase, a cysteine protease, a RNA helicase, and a RNA-dependent RNA polymerase (5, (7) (8) (9) . In the absence of a reliable in vitro culture system for HEV, fundamental studies on its replication and expression strategy have not been undertaken. ORF2 and ORF3 have been expressed in Escherichia coli, animal cells, baculovirus, yeast, and in vitro in a coupled transcription-translation system (10 -14) . ORF2, a 88-kDa glycoprotein, is expressed intracellularly as well as on the cell surface and is the major capsid protein for HEV. It is synthesized as a precursor that is processed through signal sequence cleavage into the mature protein, which is capable of self-association (15, 16) . ORF3 encodes a small 13.5-kDa phosphoprotein that is expressed intracellularly, associates with the cytoskeleton and shows no major processing (17, 18) . The ORF3 protein dimerizes using a 43-amino acid region, interacts with SH3 domains and activates cellular MAP kinase (19, 20) . Recently the phosphorylated form of the ORF3 protein has also been shown to interact with the non-glycosylated form of the ORF2 (capsid) protein of HEV (21) . These properties of ORF3 clearly indicate that this protein may have multiple roles in HEV pathogenesis. To delineate the functions of this viral protein, studies were conducted to screen and characterize ORF3-interacting host proteins from a human liver cDNA library.
Since a few years of its introduction, the yeast two-hybrid system has proven invaluable for studying physical interactions between genetically defined partners, for identifying contacts among the subunits of multiprotein complexes (22) (23) (24) (25) , and for mapping specific domains involved in protein-protein interactions (20, 21, 26) . In this system, two plasmid-borne gene fusions are co-transformed into yeast cells, and the interaction between these two fusion proteins is measured by the reconstitution of a functional transcriptional activator that triggers the expression of reporter genes lacZ and HIS3.
Using this system we have isolated an interacting partner from the human liver cDNA library, for the ORF3 protein of HEV. This interaction partner is ␣ 1 -microglobulin/bikunin precursor (AMBP), a liver-specific precursor protein. This interaction was verified using an independently cloned full-length AMBP gene, obtained from another laboratory and tested for positive interaction with ORF3, using yeast two-hybrid techniques and in vitro binding experiments. AMBP gets processed in the trans-Golgi region to give ␣ 1 -microglobulin (␣ 1 m) and bikunin, which are then secreted by the liver cells in free and bound forms. The processed protein, ␣ 1 m, was individually tested for interaction with ORF3 using the yeast two-hybrid approach, in vitro binding, immunoprecipitation, and FRET. Dual-labeling immunofluorescent staining followed by fluorescence microscopy in human liver cells showed co-localization of the ORF3 protein with ␣ 1 m; however, at 46 -48 h post-transfection, the perinuclear localization of ␣ 1 m disappeared from the cells. Experiments on subcellular localization of ␣ 1 m and using drugs that block the secretion pathway of ␣ 1 m, we showed in transfected hepatocytes, an ORF3-dependent increase in the export of ␣ 1 m from the Golgi compartment. Finally, using pulse-labeled ␣ 1 m, we have conclusively proved this observation. The biological significance of this interaction and the possible role for the accelerated export of ␣ 1 m in HEV-infected hepatocytes is discussed.
EXPERIMENTAL PROCEDURES
Strains, Media, and Plasmid Constructs-All strains, plasmids, and plasmid constructs used in this study are described in Table I . The full-length ORF3 gene of HEV was excised from the pSG-ORF3 vector (18) and cloned into the yeast two-hybrid BD vector resulting in an N-terminal in-frame fusion with the GAL4 DNA binding domain, as described before (20) . DNA manipulations were carried out as described by Sambrook, et al. (27) . All deletion constructs were generated by subcloning the full-length ORF3 genes of HEV (Table I ). All constructs were verified by restriction digestion and sequencing.
Yeast Two-hybrid Techniques-The GAL-4-based two-hybrid system, kindly provided by Dr. Stephen Elledge, containing pAS2 (DNA binding domain vector) and pACT2 (activation domain vector), together with the yeast reporter strain Saccharomyces cerevisiae Y190 (Table I) were used. The host strain containing pGBT9-ORF3 and pGAD424-ORF3 was used as a positive control (20) . The GAL4 activation domain fusion, human liver cDNA library was purchased from Clontech. The number of independent clones, as mentioned by the manufacturer, was 1 ϫ 10 6 . The average size of the cDNA insert ranged from 0.5 to 2.5 kb. The cDNA library was repeatedly transformed with the BD-ORF3 construct and transformants thus obtained were screened for Leu ϩ Trp ϩ phenotype. The Y190 host contains integrated copies of both HIS3 and lacZ reporter genes under the control of GAL4 binding sites. This yeast strain, was co-transformed with the appropriate plasmids, using the lithium acetate procedure and grown on SD plates lacking Trp and Leu (SDTrp Ϫ Leu Ϫ ). Protein interaction was tested on SD plates lacking Leu, Trp, and His (SDLeu Ϫ Trp Ϫ His Ϫ ). After 3 days at 30°C, individual colonies were streaked out and tested for liquid and filter-lift ␤-galactosidase activity, 50 mM 3-amino-1,2,3-trizole assay and for diploids showing His ϩ phenotype, using standard yeast two-hybrid procedures. The filter ␤-galactosidase assay was performed by streaking doubly transformed yeast colonies onto filter paper and allowing them to grow for 2 days on selection medium. Yeast was permeabilized by freezing yeast-impregnated filters in liquid nitrogen and thawing at room temperature. This filter was placed over a second filter that was pre-soaked in a 0.1 M phosphate buffer (pH 7.0) containing 300 mg/ml 5-bromo-4-chloro-3-indolyl-␤-D-galactopyranoside (X-gal) and 0.27% ␤-mercaptoethanol. Filters were left for 48 h to develop a blue color, which indicated a positive protein-protein interaction. The liquid ␤-galactosidase activity, a parameter directly reflecting the strength of protein-protein interactions, was determined using the substrate CPRG assay as described previously (16, 21) . Relative ␤-galactosidase activity for quantitative assays were corrected for yeast cell number and are the mean Ϯ S.E. of triplicate assays. Appropriate positive/negative controls and buffer blanks were used. The specificity of the in vivo protein-protein interaction was confirmed using a yeast genetic assay for reconfirming positive two-hybrid interactions (28) . Plasmid constructs were extracted from the positive Y190 co-transformants, separated, and verified using E. coli HB101 cells on M9 synthetic media lacking Leu. Subsequently, these plasmids were singly transformed into the PJ69-4a and PJ69-4␣ haploid yeast strains (29) . After genetic crossing, the His3 prototrophy of the diploid strains was tested by plating for growth on SDHis Ϫ media. All possible control transformations were conducted and were verified to be negative for His3 prototrophy.
In Vitro Transcription/Translation Assay-The full-length ORF3 protein (pSG-His ORF3, encoding 123 amino acids and ORF3 with an N-terminal His 6 tag) and radiolabeled 35 [S]methionine proteins (AMBP, R352, and ␣ 1 m; described in Table I ) were expressed in separate reactions using a coupled in vitro transcription-translation system (TNT coupled reticulocyte lysate system; Promega) as per the manufacturer's instructions. The unlabeled ORF3 protein was bound to Ni-NTA beads (Amersham Biosciences) and washed thrice with PBS (pH 7.4). The [ 35 S]methionine-labeled proteins were then added to the same tube and incubated for 4 h at 4°C with gentle shaking. The beads were washed three times with PBS, resuspended in 25 l of SDS-PAGE loading buffer (50 mM Tris-HCl, pH 6.8, 5% 2-mercaptoethanol, 2% SDS, 0.1% bromphenol blue, 10% glycerol) and boiled for 4 min to dissociate the bound proteins. Aliquots (10 l) of the supernatants were subjected to SDS-PAGE, and the 35 [S]methionine-labeled proteins were detected by autoradiography.
Transfection and Labeling of Cultured Cells-Human hepatoma (Huh7) cells were maintained in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum and 20 g of gentamicin per ml. Cells were transfected at about 50% confluency with plasmid DNA by using Lipofectin (Invitrogen) according to the manufacturer's guidelines. For each 60-mm diameter culture dish, 2.5 g of DNA and 10 l of Lipofectin were used in 1.2 ml of DMEM without serum or antibiotics, and DNA uptake allowed to proceed for 6 h at 37°C in a CO 2 incubator.
Forty hours post-transfection, cells were washed with 3 ml of methionine-deficient DMEM (Invitrogen) and metabolically labeled with Immunoprecipitation-Transfected, PBS-washed Huh7 cells were harvested directly in 0.5 ml of GST binding buffer (20 mM Tris (pH 7.9), 180 mM KCl, 0.2 mM EDTA, 5 mM MgCl 2 , 1 mM phenylmethylsulfonyl fluoride, 0.01% Nonidet P-40, 1 mM dithiothreitol containing 1 g/ml bovine serum albumin) after incubation on ice for 15 min. Lysates were clarified at 10,000 ϫ g for 10 min, and the supernatant was incubated on ice for 1 h with 5 l of rabbit antiserum. To this 100 l of a 10% suspension of binding buffer-washed protein A-Sepharose beads (Amersham Biosciences) were added, and the mixture was incubated with constant shaking at 4°C for 1 h. The beads were washed five times, each time with 0.5 ml of GST buffer, after being centrifuged at 10,000 rpm at 4°C for 10 s. Washed beads were resuspended in 50 l of SDS-PAGE loading buffer, heated at 100°C for 4 min, centrifuged, and the supernatant was subjected to SDS-PAGE and autoradiography or fluorography.
For detection of ␣ 1 m, human hepatoma (Huh7) cells were mock transfected with vector only or with a ORF3-expressing plasmid and allowed to grow for 39 h following which they were starved in cysteine methionine-deficient medium for 1 h. These cells were labeled with 100 Ci of 35 S Promix (PerkinElmer Life Sciences) in 1 ml of cysteine Ϫ methionine Ϫ medium for 1 h. The secreted ␣ 1 m was detected by direct immunoprecipitation of the growth medium, and the intracellular ␣ 1 m level was detected by lysing the cells as described above.
Pulse-chase Analysis-Forty-four hours post-transfection, Huh7 cells were starved in cysteine Ϫ methionine Ϫ medium for 1 h. These cells were subsequently supplemented with 200 Ci of 35 S Promix in 1 ml of cysteine Ϫ methionine Ϫ medium for 5 min. The cells were washed in PBS and chased in complete medium for respective time periods. Immunoprecipitation was conducted as described above.
Immunofluorescence Analysis-Huh7 cells were plated at a confluency of about 50% on coverslips a day before the transfection and grown for 18 h. 40 h post-transfection (or as specified), the PBS-washed cells were fixed with 2% paraformaldehyde in PBS at room temperature for 10 min, permeabilized with 100% methanol at Ϫ20°C for 3 min and then rehydrated with PBS for 20 min at room temperature. The cells were blocked with 5% normal goat serum for 2 h at room temperature and then incubated with appropriately diluted primary antibodies in PBS/0.5% Tween 20 (PBST) containing 1% normal goat serum for 2 h at room temperature. The primary antibodies used were: monoclonal anti-ORF3 at 1:200 dilution, polyclonal anti-␣ 1 m at 1:1000 dilution, or antibikunin at 1:500 dilution. Cells were washed thrice with PBS for 5 min each and then incubated for 1 h at room temperature with a 1:1000 dilution of conjugated secondary antibodies. For co-localization experiments, the secondary antibodies used were goat anti-rabbit IgG or goat anti-mouse IgG coupled to either Alexa594 (red) or Alexa488 (green) dyes (Molecular Probes, Eugene, OR). The secondary antibodies used for labeling ORF3, ␣ 1 m or bikunin, are specified in individual experiments. For localization studies using different organelle markers, fluorescent protein-expressing constructs were transfected alone or with pSGORF3, Ds-Red that was targeted to ER (ER Ds-Red), Ds-Red that was targeted to mitochondria (Mito Ds-Red), yellow fluorescent fusion protein targeted to the Golgi apparatus (YFP-Golgi) were obtained from Clontech. For experiments using Brefeldin A and monensin, these drugs were added 1 h before fixing the cells. The final concentration used was 10 g/ml for Brefeldin A and 5 M for monensin. Cells were processed as earlier and mounted in 90% glycerol in PBS. Fluorescence images were collected using a 60ϫ planapo objective in a Bio-Rad 1024 LSM attached to a Nikon inverted microscope. To prevent cross-talk in dual labeling experiments, only one dye was excited at a time, keeping the other channel completely closed. The images were processed using Confocal Assistant followed by Adobe Photoshop version 5.0.
FRET Analysis-COS-1 cells were plated on coverslips and transfected with Lipofectin as described above with expression vectors for the ECFP-ORF3 and EYFP-␣ 1 m fusion proteins. Forty-eight hours posttransfection, the coverslips were washed with PBS, fixed in 4% paraformaldehyde for 15 min at room temperature, and washed once again in PBS. These were then mounted using Antifade (Bio-Rad) and sealed with silicon sealant. A planapo 60ϫ numerical aperture/1.4 oil immersion objective (Nikon, Japan) with a 2100 Radiance Unit confocal microscope (Bio-Rad) was used for all experiments. Confocal images were acquired sequentially using the 457-nm (ECFP) and the 514-nm (EYFP) laser lines of the argon laser. Images of the ECFP emission were collected using a 500 DCLPXR dichroic mirror with an HQ 485/30 emission filter. The EYFP emission images were collected using a 560 DCLPXR dichroic mirror with an HQ 545/40 emission filter. FRET was detected using the acceptor photobleaching approach as follows. Cells expressing the ECFP and EYFP fusion proteins were first imaged sequentially, followed by specific photobleaching of the acceptor fluorophore (EYFP) by 10 -15 min of continuous illumination with the 514-nm laser line at 500 lines per second speed with a 80% laser intensity to ensure complete photobleaching of EYFP. At the end of 15 min, cells were imaged once again. Laser Pix 2000 software (Bio-Rad) was used for quantitating the mean fluorescence intensity of ECFP emission in areas of co-localization before and after photobleaching of EYFP. Change in mean fluorescence intensity before and after photobleaching of areas where the two proteins did not co-localize served as an internal control. The increase in ECFP emission, which is a direct measure of FRET efficiency, was calculated as E% ϭ [1 Ϫ (ECFP emission before EYFP photobleach/ECFP emission after EYFP photobleach)] ϫ 100. For presentation, the original images were processed using Photoshop (Adobe Systems, Mountain View, CA). Zafarullah et al. (27) RESULTS
Screening of the Human Liver cDNA Library for Cellular Proteins That
Interact with ORF3-Although the function of the ORF3 protein of HEV is yet unknown, preliminary indications clearly point to its involvement in various cellular pathways and functions (16 -19) . To identify the cellular proteins that might interact with the ORF3 protein, we used the yeast two-hybrid system to screen a human liver cDNA library. Fulllength ORF3, fused in-frame to the GAL4 binding domain in pAS2 vector, was used as "bait" to screen the cDNA library, which contained in-frame fusions with the GAL4 activation domain cloned into the pACT2 vector. The plasmids, containing the BD-ORF3 fusion (pAS2-ORF3) and the liver library activation domain fusion (pACT2-LL) DNA, were co-transformed into the yeast host strain (Y190) phenotype and ␤-galactosidase ϩ phenotype was specific to the interacting proteins. Liquid ␤-galactosidase activity was determined for the positive clones along with all appropriate negative and positive controls using the substrate chlorophenol red ␤-D-galactopyranoside, as shown in Fig. 1B .
The AD-LL interacting plasmid was isolated using standard yeast two-hybrid techniques. The interaction was verified using the genetic yeast two-hybrid approach (28) . Our genetic crosses of the haploid strains, containing singly transformed putative interacting fusion partners BD-ORF3 and AD-LL, resulted in diploids containing both interacting plasmids and showed positive His3 reporter gene activity (Fig. 1C) . The interacting plasmid AD-LL was digested using restriction enzymes, and the insert size was estimated at 1.1 kb. This 1.1-kb insert was sequenced from one end, and the sequence obtained was subjected to the NCBI-BLAST search. This revealed a 100% homology with a gene encoding ␣ 1 -microglobulin/bikunin precursor (AMBP; gene accession number: XO4494).
AMBP is made up of two unrelated plasma glycoproteins, ␣ 1 -microglobulin (␣ 1 m) and bikunin. These are processed following intracellular proteolytic cleavage and are found in a free state as well as complexed with other plasma proteins ( Fig.  2A) . ␣ 1 m is a member of the lipocalin superfamily and is postulated to have a role in immune regulation (30) . Bikunin is a Kunitz-type serine protease inhibitor that provides the inter-␣-inhibitor family members with their enzyme inhibitory capacity (31) . Despite their lack of any structural or functional relationship, both proteins originate from a shared polypeptide; AMBP, which is encoded by a single copy gene. From rodents to primates, the AMBP gene is exclusively expressed in liver (31) . AMBP produces a 1.2-kb mRNA, which is translated into a polyprotein with a 19-amino acid signal peptide. The AMBP cDNA isolated from the human liver library contained an Nterminal deletion of 32 amino acids that would contain the signal sequence comprising of the first 19 amino acids and the remaining 13 amino acids from ␣ 1 m (Fig. 2B) .
Interaction of Full-length AMBP with ORF3-To validate our findings we obtained the full-length AMBP cDNA (referred to as R352) as a gift from Dr. Jean-Philippe Salier. R352 was cloned in-frame, into the yeast two-hybrid binding domain vector as an N-terminal fusion (Table I ). This BD-R352 fusion protein was cotransformed along with AD-ORF3, into the Y190 yeast strain. Co-transformants were isolated and tested for His ϩ prototrophy and ␤-galactosidase activity on filter and liquid assays (Fig. 2C) was individually tested for its interaction with ORF3. Yeast two-hybrid analysis showed that ␣ 1 m interacted with ORF3 (Fig. 3) . Compared with previously observed protein-protein interactions in our laboratory (16, 20, 21) , this was a relatively weak interaction.
To further confirm these interactions, we also used an in vitro approach. The full-length ORF3 gene was cloned with an N-terminal His 6 tag into the pSGI vector (Table I ). The His 6 -ORF3 protein was expressed using the rabbit reticulocyte lysate-coupled transcription-translation system as described previously (21) . In separate reactions, [ 35 S]methionine was used to radiolabel proteins expressed from pSG-AMBP, pSG-R352, and pSG-␣ 1 m (Table I ). Unlabeled His 6 -ORF3 was bound to charged Ni-NTA beads, and these beads were then used to trap 35 S-labeled AMBP, R352, or ␣ 1 m. In separate control experiments, approximately equal amounts of each 35 S-labeled protein was added to tubes with charged Ni-NTA beads in the absence of ORF3. After 4 h of gentle shaking at 4°C, the beads were washed to remove all unbound protein, and the bound proteins were analyzed by SDS-PAGE and autoradiography. The results of this experiment are shown in Fig. 3A . The control experiments showed clearly that none of the proteins bound to Ni-NTA beads in the absence of ORF3 (Fig. 3A, lanes  1-3) . AMBP, R352, and ␣ 1 m (Fig. 3A, lanes 5-7) clearly showed good binding to ORF3 in vitro.
We further studied the ␣ 1 m-ORF3 interaction in animal cells. Mammalian COS-1 cells were transiently transfected with pMT-ORF3 alone or together with pMT-␣ 1 m (Table I) . [ 35 S]Methionine-labeled cell lysates were immunoprecipitated using anti-ORF3 antibodies.
When ␣ 1 -microglobulin was co-transfected with ORF3 in COS-1 cells and immunoprecipitated using anti-ORF3 antibodies, this protein was detected in the autoradiogram (Fig. 3B,   lane 4) . Appropriate single transfection controls did not show immunoprecipitation of ␣ 1 m with the anti-ORF3 antibodies (Fig. 3B, lanes 1-3) .
Co-localization of ␣ 1 -Microglobulin with ORF3-To understand the subcellular localization of ␣ 1 m, we used Huh7 hepatoma cells, which endogenously express ␣ 1 m. These cells were subjected to immunofluorescent staining followed by fluorescence microscopy. For studying co-localization of ORF3 with ␣ 1 m, dual labeling experiments were carried out in which Huh7 cells were transiently transfected with pMT-ORF3. The distribution of ORF3, as observed previously (19, 21) , was cytoplasmic and displayed punctate staining (Fig. 4, B and E) . The endogenously expressed ␣ 1 m protein was cytoplasmic in distribution, with distinct perinuclear staining, possibly in the ER (Fig. 4, A and D) . In dual labeling experiments, distinct orange to yellow stained regions were observed in merged images indicating co-localization of ORF3 with ␣ 1 m. These yellow regions were primarily perinuclear (Fig. 4, C and F) .
FRET Measurements of the ORF3-␣ 1 m Interaction-We used fluorescence resonance energy transfer (FRET) to detect the ORF3-␣ 1 m interaction in vivo and to complement the results of in vitro interaction assays. This non-radiative energy transfer follows stringent conditions of distance and dipole orientations between the donor and acceptor fluorophores. Proteins fused to the cyan (ECFP) and yellow (EYFP) colored variants of the enhanced green fluorescent protein (EGFP) were used as the donor-acceptor FRET pair (30) . The efficiency of FRET was measured following cotransfection of COS-1 cells as described under "Experimental Procedures." To make measurements independent of the expression levels of the two fusion proteins, we followed an acceptor photobleach protocol and recorded the mean fluorescence intensity from the donor fluorophore (ECFP) before and after photobleaching of the acceptor fluoro- phore (EYFP) (32) (33) (34) (35) . Three areas within the same cell were recorded, two regions where both proteins co-localized (A and B) and a third region where no co-localization was observed (C) (Fig. 5 ). An average percent FRET efficiency of ϳ12.18 was found in the regions of co-localization as opposed to ϳ3.76 in the region where the two proteins do not co-localize. The difference in pixel intensity of ECFP before and after photobleaching of EYFP in the areas of co-localization and the region where the two proteins do not co-localize when compared for 16 independent observations showed high levels of significance with a p value of 4.52 ϫ 10 Ϫ8 . Because FRET efficiency between two molecules decreases by the sixth power of the distance between them (33), the presence of FRET indicates an actual proteinprotein interaction. Simple co-localization of two proteins is not sufficient to yield energy transfer, and FRET represents a powerful indicator of in vivo protein-protein interactions. The ECFP-EYFP pair is a commonly used donor/acceptor pair, ideally suited for FRET measurements. FRET exploits the ability of the higher energy donor fluorophore (ECFP) to transfer some of its energy to the acceptor fluorophore (EYFP) in its excited state under optimum conditions of spectral overlap and Forsters radius (33) . Following FRET, there is a reduction in the donor emission due to the transfer of energy and an increase in the acceptor emission. We show here weak, but significant FRET efficiency between ECFP-ORF3 and EYFP-␣ 1 m, supporting the in vitro and yeast two-hybrid results that the ORF3 protein and ␣ 1 m interact with each other.
Hepatocytes Expressing ORF3 Show Leaching of ␣ 1 m-ORF3-expressing liver cells, when stained with anti-␣ 1 m antibodies, showed absence of the distinct perinuclear staining, which was observed in cells not expressing ORF3. The number of cells showing this phenomenon increased with time as observed at 40, 44, and 48 h post-transfection. These observations gave preliminary indications that the intracellular processing and export of processed ␣ 1 m increased in the presence of the ORF3 protein within the hepatocyte. Fig. 6 shows a representative field at the 48-h time point. Panel A of Fig. 6 shows expression of the fusion cyan fluorescent protein-ORF3 localizing in the cytoplasm. The same field was observed under the red filter to check the level of ␣ 1 m. ORF3-expressing cells (large arrows) and cells not expressing ORF3 (small arrows) can be visualized in the same field in Fig. 6B . In this experiment the perinuclear localization of ␣ 1 m can be clearly visualized in non-ORF3-expressing cells (36, 37) . This distinct localization of ␣ 1 m is completely absent in ORF3-expressing cells. To show that this effect was specific to ␣ 1 m, we measured the extracellular levels of a completely unrelated secretory protein, laminin, in ORF3-expressing cells and compared it to non-ORF3-expressing cells. There was no difference in the level of laminin in ORF3-expressing and mock treated cells (data not shown). This data was statistically quantified by visualizing a total of 200 ORF3-expressing cells and scoring them for presence or absence of ␣ 1 m (Table II) Furthermore, experiments were designed to detect the cellular compartments where ORF3 exerted its effect on ␣ 1 m, we designed an immunofluorescence assay with different organelle markers to check the status of ␣ 1 m in various subcellular components in the presence or absence of the ORF3 protein.
ORF3 Enhances Clearance of ␣ 1 m from the Golgi Apparatus-The CFP-ORF3 plasmid construct was transfected, along with mitochondria, ER, and Golgi-specific fluorescent markers. ␣ 1 m localization was visualized in the mitochondria, ER, and Golgi of hepatocytes expressing ORF3 and compared with mock transfected cells that were not expressing ORF3. ␣ 1 m was detected by staining with Alexa 488 (green) or Alexa 594 (red) depending on the complementary color used in the experiment.
All observations were made at 48 h post-transfection (Fig. 7) . Mitochondrial marker (Mito Ds-Red) was used to visualize mitochondria. The ␣ 1 m localization in the mitochondria and the effect of CFP-ORF3 were studied (Fig. 7A, panels a-f) . Although minute amounts of ␣ 1 m were detected in the mitochondria, ORF3 expression showed no effect on its localization. Interestingly, ORF3 expression had no effect on ␣ 1 m levels in the ER either (Fig. 7A, panels g-l) . However, ORF3 expression resulted in the complete disappearance of ␣ 1 m from the Golgi region (Fig. 7A, panels m-r) . Moreover, ORF3 itself was found to be concentrated in the Golgi. 200 ORF3-transfected cells from each set of experiments were counted and scored for ␣ 1 m status. Cells showing complete disappearance of ␣ 1 m were scored positive. Data obtained from this analysis are summarized in Table III . To confirm the observation that ORF3 enhances ␣ 1 m transport from the Golgi compartment, we used Brefeldin A and monensin, two commonly used inhibitors of the secretory pathway. Brefeldin A specifically inhibits ER to Golgi transport by binding to ADP ribosylation factor guanine nucleotide exchange factor (38) . Monensin blocks protein transport beyond the trans-Golgi vesicle, resulting in intracellular accumulation of protein (39) . Fig. 7B shows the effects of Brefeldin A and monensin on ␣ 1 m leaching in the presence and absence of ORF3. 47 h post-transfection with ORF3, cells were treated with either of the two drugs for 1 h before fixing the cells for fluorescence microscopy. 500 ORF3-transfected cells were examined for the presence of ␣ 1 m within the cells. As expected, ORF3-mediated leaching of ␣ 1 m was blocked by Brefeldin A, and ␣ 1 m accumulated within the cell (Fig. 7B, panel b) . Corresponding untransfected cells stained with ␣ 1 m are visible in panel a. Monensin also produced similar effects as Brefeldin A (Fig. 7B, panel d) . Corresponding untransfected cells stained with ␣ 1 m are visible in panel c. These experiments clearly proved that the disappearance of ␣ 1 m from within the hepatocytes was due to ORF3-mediated transport through the Golgi compartment and was not due to ␣ 1 m degradation in the presence of ORF3.
Increased Secretion of ␣ 1 m from Hepatocytes Expressing ORF3-Finally, we proposed to study the levels of secreted ␣ 1 m from liver cells expressing ORF3. This experiment was conducted by metabolically labeling cells with 35 S Promix as described under "Materials and Methods." Growth medium was collected at 40, 44, and 48 h post-transfection and directly subjected to immunoprecipitation using ␣ 1 m antibody (Fig.  8A ). Significant differences were observed in the ␣ 1 m levels, in growth medium between mock-transfected cells (lanes 1, 3, and  5 ) and transfected cells expressing ORF3 (lanes 2, 4, and 6) at 40, 44, and 48 h, respectively. Densitometric units showing secreted ␣ 1 m for all three time-points were significantly different (p Ͻ 0.05) between growth media of mock transfected and ORF3-expressing cells, as shown in the bar graph. The lower panel shows corresponding cell lysates immunoprecipitated using anti-ORF3 antibody. To establish the specificity of the enhanced secretion observed in this experiment, we checked secreted levels of ␣ 1 m in the presence of EGFP and ORF2, in two separate sets of experiments (Fig. 8B) . Densitometric levels were found to be unchanged in both EGFP-and ORF2-expressing cells. As a control in this experiment, we checked the level of secreted laminin in mock transfected or ORF3-transfected cells. As expected, there was no significant difference in the level of laminin in presence of ORF3, supporting our microscopic observations (data not shown).
To further confirm that ORF3 indeed expedites the transport of ␣ 1 m from hepatocytes, we conducted a pulse-chase assay to study the kinetics of ␣ 1 m secretion in the presence and absence of ORF3. Samples of the growth media were analyzed for ␣ 1 m at different time points using antibodies against it (Fig. 8C) . Data from this experiment showed that pulse-labeled ␣ 1 m from ORF3-expressing hepatocytes reached detectable levels in the growth media at 20 min post-chase, whereas ␣ 1 m was unde- 2 and 3) in the presence of monensin is most likely due to the inhibition of Golgi-specific oligosaccharide processing by monensin. Thus from all the experiments described in these results, we conclude that the ORF3 protein interacts with ␣ 1 m and enhances its export from the hepatocytes. DISCUSSION HEV cannot be cultured routinely, although it has recently been propagated in primary macaque hepatocytes (6, 40) and a virus resembling HEV has been cultured in A549 cells (41) . Studies on HEV protein synthesis, processing, and assembly have hence been limited to heterologous gene expression systems. The ORF3 gene of HEV has been cloned and expressed in bacterial, animal cell, baculoviral, and yeast expression systems (8, 9, (13) (14) (15) , however no definite function has been assigned to it as yet. The ORF3 protein is ϳ13.5 kDa (123 amino acid), associates with the cytoskeleton, is a substrate for MAP kinase, self-associates to form dimers, binds various SH3 domain-containing proteins, and interacts with the major structural protein, ORF2 (18, 20, 21) . It also activates cellular MAP kinase (19) . These observations clearly indicate that the ORF3 protein must have multifarious activities that involve its interactions with its host cell proteins. With this idea in mind, we decided to use the yeast two-hybrid system to isolate and characterize host interacting partners for this protein. Because HEV primarily infects hepatocytes, a human liver cDNA library was screened for cellular partners.
A total of 6 ϫ 10 4 Leu ϩ Trp ϩ transformants was screened from which 100 co-transformants showed positive protein-protein interactions. The positive clones were divided into four groups, the strongest and most recurring AD-plasmid was isolated, sequenced, and analyzed using NCBI-BLAST (www.ncbi.nlm.nih.gov/BLAST/). This analysis revealed that the ORF3 protein of HEV interacts with the human ␣ 1 -microglobulin/bikunin precursor (AMBP) protein.
AMBP is a liver-specific protein that is processed to give two mature proteins, ␣ 1 -microglobulin (␣ 1 m) and bikunin. The AMBP gene has been cloned from various sources, including human (42), mouse (43) , cattle (44) , and swine (45) . The human AMBP gene consists of 10 exons, which span 1.3 kb and 9 introns with an aggregated length of about 16.5 kb and is under the control of a potent and liver-specific enhancer (46) . AMBP can dimerize (47) and is cleaved at a tripeptide bridge in the trans-Golgi compartment to yield the two unrelated processed proteins, ␣ 1 m and bikunin. Moreover, it has been shown in different expression systems that both ␣ 1 m and bikunin can be expressed alone (6, 33, 36, 48) . ␣ 1 m is a member of the lipocalin superfamily (30) , which is made up of nearly 20 different proteins. Although members of this family display low sequence similarity, all share a conserved folding pattern. ␣ 1 m is a glycoprotein found predominantly in free state in plasma or a variety of other plasma proteins (49) .
Liver, blood plasma, and kidney are the major sites for ␣ 1 m localization. Soon after cleavage, ␣ 1 m is released from the hepatocyte. The protein exists in free form as well as in a variety of high molecular weight complexes in serum where its concentration remains unchanged (50) . Besides a one-to-one complex with monomeric IgA, ␣ 1 m is also linked to albumin and prothrombin (49) . In rat serum, it forms complexes with fibronectin (51) and proteinase inhibitor-␣ 1 -inhibitor-3, a homologue of human ␣ 2 -macroglobulin (52) . Although the biological function of ␣ 1 m is not known, it has been shown to possess a number of immunoregulatory properties in vitro. It inhibits the antigen-induced proliferation of peripheral lymphocytes, interleukin-2 production of T-cells, and the migration and chemotaxis of granulocytes (47, 53, 54) . These properties of ␣ 1 m suggest that it has a general immunosuppressive role.
Our studies show that the ORF3 protein of HEV interacts with AMBP and its processed protein, ␣ 1 m. The ORF3-␣ 1 m interaction was found to be weak; nonetheless it was detectable in all the yeast two-hybrid assays, FRET analysis, immunoprecipitations, and in vitro transcription-translation binding assays.
Human hepatoma Huh7 cells expressing AMBP endogenously when stained with anti-␣ 1 m antibodies showed perinuclear staining characteristic of proteins translocating to the ER. AMBP is processed in the trans-Golgi to ␣ 1 m, which is in turn transported in a free or bound form, out of the hepatocyte. Using dual staining immunofluorescent microscopy of liver cells, endogenously expressing AMBP, ␣ 1 m was shown to colocalize with the ORF3 protein. ORF3 showed punctate staining in the cytoplasm, however on dual staining with anti-␣ 1 m and anti-ORF3 antibodies, co-localization was evident in the perinuclear region. Furthermore, we observed a distinct difference in the cellular localization patterns of ␣ 1 m in hepatocytes expressing ORF3, 44 and 48 h post-transfection. An increasing number of transfected hepatocytes showed an absence of distinct perinuclear ␣ 1 m staining observed in hepatocytes expressing ORF3. Transfected cells expressing ORF3 showed colocalization with ␣ 1 m at 40 h post-transfection; however, at 44 h and further at 48 h post-transfection, increasing numbers of hepatocytes expressing the ORF3 protein showed complete disappearance of ␣ 1 m from within the cell. This phenomenon of a "shift" from perinuclear localization to a complete absence of detectable ␣ 1 m within the liver cell, steadily increased with increasing post-transfection time. We then further studied in more detail the intracellular secretory pathway through which ␣ 1 m gets cleared in ORF3-expressing cells. Experiments using organelle-specific markers clearly proved that ␣ 1 m disappearance occurs from the Golgi compartment and that ORF3 expression had no effect on the levels of ␣ 1 m inside ER.
Furthermore, experiments using monensin and Brefeldin A, two drugs that disrupt the protein transport machinery within the cell by disrupting ER to Golgi membrane traffic and impairing post-Golgi trafficking, respectively, showed that ORF3-mediated ␣ 1 m disappearance was sensitive to both the drugs.
There was intracellular accumulation of ␣ 1 m due to a block in intracellular traffic. This increase in ␣ 1 m within the hepatocyte is evident by a shift from the predominantly perinuclear localization of ␣ 1 m to a more diffuse cytoplasmic accumulation of the protein, as observed. Moreover, this experiment also proved that ORF3-mediated disappearance of ␣ 1 m with time was not due to the degradation of the latter. Finally by metabolic labeling and pulse-chase experiments, we were able to clearly establish that the ORF3 protein enhances the export of ␣ 1 m out of the hepatocyte. Inhibitory effects of ␣ 1 m on the immune system are well studied. ␣ 1 m suppresses antigen-induced polyclonal proliferation of cultured lymphocytes (55) . It also inhibits spontaneous migration of neutrophil granulocytes in vitro and suppresses the chemotactic attraction of granulocytes by a cytokine concentration gradient released by triggered monocytes, macrophages and B-and T-lymphocytes (56) . It is also known that infiltrating lymphocytes in the HEV-infected liver have cyto- toxic or suppression immunophenotype (57) . Although the plasma levels of ␣ 1 m do not change during inflammation, the local effects exerted by them have been well documented (58 -62) . Our studies showing enhanced export of the ␣ 1 m protein in the presence of a viral protein (ORF3) support the hypothesis of an immunosuppressive environment being created around the infected liver cells by virtue of increased localized secretion of ␣ 1 m.
